Live feed16:00:00·10dPRReleasevia QuantisnowBelite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt DiseaseByQuantisnow·Wall Street's wire, on your screen.BLTE· Belite Bio IncHealth Care
